Our news News & Events

4P-Pharma, a clinical-stage biotechnology company and the research center Institut de la Vision (Sorbonne Université, Inserm, CNRS) establish a partnership agreement for the development of 4P020, a promising therapeutic approach for dry age-related macular degeneration (dAMD) and Stargardt disease with the support of the SATT Lutech. This drug candidate, initially studied by Dr Valerie Fontaine at the Institut de la Vision, opens&hellip

Our chairwoman, Revital Rattenbach, will attend the Biotech Showcase, January 11th – 15th online. Contact us via the partnering platform or by e-mail to schedule a virtual meeting and discuss collaboration opportunities. For more information : https://informaconnect.com/biotech-showcase/

The entire 4P-Pharma team wishes you a happy 2021 ! May this new year be a source of achievement and joy for you and your loved ones Design by Valérie Baudry

4P-Pharma’s CSO, Patrice Denèfle, will give a talk on 4P004 : « Accelerating therapeutic innovation for patient through drug repurposing : a use case in Osteoarthritis » at the Drug Discovery Innovation Programme (DDIP) virtual meeting organized by the World BI, on November, 17th 2020, 10:00 a.m CET. To learn more about 4P-Pharma, our pipeline&hellip

Pr. Francis Berenbaum (Head of Rheumatology at Saint-Antoine Hospital, and Professor of Rheumatology at Sorbonne University, in Paris, France) will present a poster on 4P004 entitled “Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration in Osteoarthritis: In Vitro and In Vivo Studies Supporting a Pro-Chondrogenic Effect” (#0703) during the ACR Convergence 2020 annual meeting, November&hellip

4P-Pharma is in the Silicon Review’s “50 Fastest Growing Companies of the Year 2020” list. The Silicon Review recognizes worldwide companies to follow closely! Here you can find the Silicon Review’s interview of Revital Rattenbach, our chairwoman, and Patrice Denèfle, our CSO, about 4P-Pharma’s DNA and the challenging field of drug development:   https://thesiliconreview.com/magazine/profile/speed-up-innovation-with-4p-pharmas-unique-drug-discovery/